Verve Therapeutics, Inc.
General ticker "VERV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $488.1M (TTM average)
Verve Therapeutics, Inc. follows the US Stock Market performance with the rate: 32.5%.
Estimated limits based on current volatility of 0.9%: low 11.11$, high 11.22$
Factors to consider:
- Current price 16.6% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.60$, 9.69$]
- 2025-12-31 to 2026-12-31 estimated range: [3.68$, 9.65$]
Financial Metrics affecting the VERV estimates:
- Negative: Non-GAAP EPS, $ of -2.35 <= 0.05
- Negative: negative Net income
- Negative: Operating profit margin, % of -87.61 <= 0.04
- Negative: Operating cash flow per share per price, % of -23.50 <= 1.99
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: Shareholder equity ratio, % of 76.21 > 63.58
Short-term VERV quotes
Long-term VERV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.94MM | $11.76MM | $32.33MM |
| Operating Expenses | $167.63MM | $234.88MM | $260.99MM |
| Operating Income | $-165.69MM | $-223.12MM | $-228.66MM |
| Non-Operating Income | $8.35MM | $23.33MM | $30.30MM |
| R&D Expense | $130.09MM | $184.95MM | $204.35MM |
| Income(Loss) | $-157.33MM | $-199.79MM | $-198.36MM |
| Taxes | $0.05MM | $0.28MM | $0.35MM |
| Profit(Loss)* | $-157.39MM | $-200.07MM | $-198.71MM |
| Stockholders Equity | $550.93MM | $599.50MM | $493.40MM |
| Assets | $679.22MM | $752.69MM | $647.39MM |
| Operating Cash Flow | $-122.33MM | $-149.55MM | $-157.69MM |
| Capital expenditure | $13.23MM | $9.28MM | $3.74MM |
| Investing Cash Flow | $-155.96MM | $27.69MM | $74.88MM |
| Financing Cash Flow | $328.96MM | $212.58MM | $49.20MM |
| Earnings Per Share** | $-2.91 | $-3.12 | $-2.35 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.